Skip to main content

Plaintiff's Motion For a New Bair Hugger Trial Rejected

Plaintiff's Motion For a New Bair Hugger Trial Rejected

Plaintiff's Motion For a New Bair Hugger Trial Rejected

Introduction

In an order issued on October 27, Minnesota federal judge Joan N. Ericksen denied a couple's motion for a new trial in the first Bair Hugger bellwether case against 3M. The order stated that the court did not exclude evidence that would have helped the plaintiff prove the design defect in the warming blanket.

The plaintiff from South Carolina sought to admit the evidence of the defendant's "knowledge of risk-utility." However, under South Carolina law, the focus in a strict liability "centers upon the alleged defectively designed product’’ and not the manufacturer's mental state. Plaintiff’s claims of negligence, failure to warn, deceptive trade practices, and misrepresentation were all dismissed on summary judgment in June 2018. The plaintiff suffered a deep joint infection in 2010 for which he underwent a total right knee replacement surgery when a 3M Bair Hugger warming blanket was used. In the lawsuit filed against 3M, the plaintiff blamed the defective design of the product which required him to undergo several antipsychotic treatments and revision surgery.

The second bellwether trial begins in December 2018, involving claims by a couple from Idaho. More than 4,467 hip and knee infection lawsuits are filed against the Bair Hugger warming blanket maker. Similar cases are consolidated into multidistrict litigation (MDL 15-2666; In Re: Forced Air Warming Devices Products Liability Litigation) in the District of Minnesota.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.